XML 21 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Rental income $ 18,523,813 $ 17,392,397
Fees and other income 401,462 243,217
Total revenue 18,925,275 17,635,614
Costs and expenses:    
Rental operating costs 6,256,077 5,962,918
General and administrative 7,526,675 6,790,432
Depreciation and amortization 5,515,518 5,425,739
Asset Impairment Charges 1,969,311 3,247,097
Total costs and expenses 21,267,581 21,426,186
Other income (expense):    
Interest and other income, net (151,356) 1,435,298
Gain on sales of real estate, net 3,426,572 3,240,200
Net loss in Conduit Pharmaceuticals marketable securities (see footnote 9) (17,925,723) (23,359,774)
Gain on deconsolidation of SPAC (see footnote 9) 0 40,321,483
Income tax (expense) benefit (60,855) 335,780
Total other (loss) income, net (20,761,558) 16,968,098
Net (loss) income (23,103,864) 13,177,526
Less: Income attributable to noncontrolling interests (2,524,665) (3,031,080)
Net (loss) income attributable to Presidio Property Trust, Inc. stockholders (25,628,529) 10,146,446
Less: Preferred Stock Series D dividends (2,236,696) (2,118,846)
Net (loss) income attributable to Presidio Property Trust, Inc. common stockholders $ (27,865,225) $ 8,027,600
Net (loss) income per share attributable to Presidio Property Trust, Inc. common stockholders:    
Basic & Diluted (in dollars per share) $ (2.25) $ 0.68
Weighted average number of common shares outstanding - basic & dilutive (in shares) 12,386,594 11,847,814
Mortgage Notes [Member]    
Other income (expense):    
Interest expense - mortgage notes $ (6,050,196) $ (5,004,889)